Automated insulin delivery with the <scp>MiniMed</scp> ™ <scp>780G</scp> system reduces burden by improving sleep and glycaemic control overnight
The MiniMed™ 780G system includes technology developed by DreaMed Diabetes (Petah Tikvah, Israel). All authors are employees of Medtronic Diabetes. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.70380. The proprietary datasets generated and analysed for the current study are not publicly available but can be made available from the corresponding author upon reasonable request.
Authors
- Fang Niu (ORCID: https://orcid.org/0000-0002-5035-7409)
- Arcelia Arrieta (ORCID: https://orcid.org/0009-0003-1684-0258)
- NAVEEN MATHEW NATHAN SATHIYANATHAN
- Margaret Liu
- Robert A. Vigersky
- Jennifer J. F. McVean
- John Shin
Institutions
- Medtronic (Ireland) (IE)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1111/dom.70380
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00